no differences in mortality or remission rates were observed. Thus, plasma exchange does not have an established benefit for patients with alveolar hemorrhage and is associated with an increased risk of serious infection (see above recommendation). Plasma exchange may be considered for certain patients with active glomerulonephritis or those who are critically ill and whose disease is not responding to recommended remission induction therapies (i.e., plasma exchange as "salvage" or "rescue"